The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.

ImmunityBio shares plunge 9% after $48.84 million revenue miss

Nov 13, 2026 00:48 (2h ago)

Verifying

ImmunityBio shares fell 9% to $6.07 on Thursday, extending a four-day losing streak.
Revenue reached $48.84 million, up 52% year over year but below estimates of $59.2 million to $61 million.
ImmunityBio is scheduled to attend two London healthcare conferences on Monday, November 16.